BioUtah has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown, offering reduced pricing until October 17 for the November 12 event at the Hilton Salt Lake City Center. The summit typically attracts over 500 registrants and convenes life sciences leaders, experts, policymakers, and professionals to discuss industry dynamics, regulatory landscapes, market trends, and strategies for promoting innovation and advancing healthcare. Kelvyn Cullimore, president and CEO of BioUtah, emphasized the event's significance, stating that it brings together the best in the sector for discovery, collaboration, and inspiration.
The summit occurs as Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs throughout the state and beyond. This economic impact underscores why the summit matters for maintaining Utah's competitive position in the life sciences industry. The event features prominent keynote speakers including Melissa Holyoak, Commissioner of the Federal Trade Commission, who brings expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions. Her participation signals the importance of regulatory considerations in the rapidly evolving life sciences landscape.
Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will conduct a virtual FDA Town Hall discussion about the agency's policy priorities and regulatory initiatives. This direct engagement with FDA leadership provides crucial insights for companies navigating complex approval processes. Other notable speakers include Peter Marks, MD, former head of the FDA's Center for Biologics Evaluation and Research, who oversaw expansion in FDA-approved cell and gene therapies and played a key role in establishing Operation Warp Speed for COVID-19 vaccine development. His experience highlights the summit's focus on cutting-edge medical innovations.
Carter Dredge, Executive Director of the Intermountain Health Institute, will share insights as a global healthcare thought leader working with top thinkers to create novel solutions to complex problems. The summit includes dedicated networking programs designed to facilitate meaningful professional connections during lunch sessions. Attendees can register at https://bioutah.org/summit-registration to secure early bird pricing. The event will feature multiple subject-specific tracks covering workforce development, market access, regulatory and quality standards, and legal considerations.
BioUtah will also present awards throughout the day recognizing individuals and companies for their contributions and achievements in the life sciences sector. According to Cullimore, the summit offers relevant content whether participants focus on medical device manufacturing, diagnostics, or biopharmaceuticals. The preliminary agenda available at https://bioutah.org/summit-agenda shows comprehensive programming addressing the most pressing issues facing Utah's $22.6 billion life sciences industry and its approximately 180,000-strong workforce. This gathering matters because it directly addresses the challenges and opportunities in a sector that represents a significant portion of Utah's economy and healthcare innovation ecosystem.
